Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventions

• Published in: International journal of infectious diseases Vol. 103; pp. 146 - 153
• Main Authors: Zimmermann, Ruth, Faber, Mirko, Dudareva, Sandra, Ingiliz, Patrick, Jessen, Heiko, Koch, Judith, Marcus, Ulrich, Michaelis, Kai, Rieck, Thorsten, Ruscher, Claudia, Schilling, Birte, Schumacher, Jakob, Sissolak, Dagmar, Thoulass, Janine, Wenzel, Jürgen J., Werber, Dirk, Sagebiel, Daniel
• Format: Journal Article
• Language: English
• Published: Canada Elsevier Ltd 01.02.2021; Elsevier
• Subjects: Adolescent; Adult; Aged; Berlin - epidemiology; Disease Outbreaks - prevention & control; Germany; HAV; Hepatitis A; Hepatitis A - epidemiology; Hepatitis A - prevention & control; Homosexuality, Male; Humans; Male; Middle Aged; MSM; Odds Ratio; Outbreak; Sexual and Gender Minorities; Vaccination; Vaccination - statistics & numerical data; Vaccination coverage; Vaccination Coverage - statistics & numerical data; Young Adult; Berlin; Germany; Outbreak; Vaccination coverage; HAV; MSM; Vaccination; Hepatitis A
• ISSN: 1201-9712; 1878-3511
• DOI: 10.1016/j.ijid.2020.11.133

•The outbreak in Germany’s gay hotspot Berlin included 222 cases, most self-identifying as MSM.•Hepatitis A vaccination is recommended and free of charge for MSM in Germany.•The vaccination coverage was low among MSM, in particular among young and foreign-born.•Various measures were implemented targeting the MSM community, physicians, and the public.•Increased vaccination uptake shows the success of the interventions. To describe the characteristics of a large hepatitis A virus (HAV) outbreak among men who have sex with men (MSM) in Berlin and to assess the impact of measures implemented. Cases of laboratory-confirmed, symptomatic HAV infection notified in Berlin, Germany between August 2016 and February 2018 were analysed using routine and enhanced surveillance data including genotyping results. Several studies involving different groups of participants were conducted to further investigate the outbreak, including surveys on knowledge and practices of HAV vaccination among physicians and vaccination coverage and determinants of vaccination status among MSM. The measures implemented were categorized by target group in a Gantt chart. To assess their impact, health insurance data on HAV vaccination uptake were analysed, comparing Berlin and other federal states. During the outbreak period, a total of 222 cases were reported (of which 91 were sequence-confirmed), with a peak in case numbers in January 2017. Physicians were aware of the existing vaccination recommendations, but vaccination coverage among 756 MSM was low, with 32.7% being completely vaccinated and 17.3% being incompletely vaccinated before 2017. HAV vaccination before 2017 was associated with being born in Germany (odds ratio 2.36) and HIV-positive (odds ratio 1.80). HAV monovalent vaccination uptake increased by 164% from 2016 to 2017 among males in Berlin, compared to 7% in other federal states. Multiple measures targeting the MSM community, physicians, and public health to increase HAV vaccination uptake were successfully implemented. To prevent future HAV outbreaks, we recommend monitoring vaccination coverage among MSM, promoting awareness of existing recommendations among physicians, and ensuring access for foreign-born and young MSM.